0.45
price up icon0.22%   0.001
after-market After Hours: .46 0.01 +2.22%
loading
Acurx Pharmaceuticals Inc stock is traded at $0.45, with a volume of 709.58K. It is up +0.22% in the last 24 hours and down -37.50% over the past month. Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$0.449
Open:
$0.41
24h Volume:
709.58K
Relative Volume:
0.12
Market Cap:
$13.23M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.3913
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-4.86%
1M Performance:
-37.50%
6M Performance:
-49.04%
1Y Performance:
-82.28%
1-Day Range:
Value
$0.41
$0.4571
1-Week Range:
Value
$0.40
$0.49
52-Week Range:
Value
$0.30
$2.75

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
Name
Acurx Pharmaceuticals Inc
Name
Phone
917-533-1469
Name
Address
259 LIBERTY AVENUE, STATEN ISLAND
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
ACXP's Discussions on Twitter

Compare ACXP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACXP
Acurx Pharmaceuticals Inc
0.45 13.91M 0 -14.58M -9.80M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Acurx Pharmaceuticals Inc Stock (ACXP) Latest News

pulisher
06:41 AM

Acurx Pharmaceuticals Inc. Stock Analysis and ForecastPowerful growth strategies - Jammu Links News

06:41 AM
pulisher
04:15 AM

What drives Acurx Pharmaceuticals Inc. stock priceFree Capital Efficiency Planning - Jammu Links News

04:15 AM
pulisher
Jul 18, 2025

What analysts say about Acurx Pharmaceuticals Inc. stockFree Risk Assessment Services - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What risks could impact Acurx Pharmaceuticals Inc. stock performanceFree Stock Market Analysis Courses - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Acurx Pharmaceuticals Holds Annual Meeting and Elections - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Acurx Pharmaceuticals shareholders approve board proposals at annual meeting - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Acurx Pharmaceuticals shareholders approve board proposals at annual meeting By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Acurx Pharmaceuticals files $50M mixed shelf offering - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

How Acurx Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Acurx Files to Sell 9.16M Shares of Common Stock for Holders - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Acurx Pharmaceuticals Inc. stock price move sharplyFree Exclusive Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Stock Price Up 3.6% – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jun 27, 2025

ACXP SEC FilingsAcurx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 27, 2025
pulisher
Jun 20, 2025

ACXP raises $2.3M via warrant inducement, issues 9.1M new warrants - Stock Titan

Jun 20, 2025
pulisher
Jun 18, 2025

Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year? - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Investors Purchase Large Volume of Acurx Pharmaceuticals Call Options (NASDAQ:ACXP) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Raises Fresh $2.67M Capital: New Antibiotic Development Gets Major Funding Boost - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./ - Yahoo Finance

Jun 17, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Inc (ACXP) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

US Stocks Lower; Retail Sales Decline In May - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside - FinancialContent

Jun 17, 2025
pulisher
Jun 17, 2025

Acurx Pharmaceuticals Soars as Breakthrough Antibiotic Data Hits the Headlines - RagingBull

Jun 17, 2025
pulisher
Jun 17, 2025

Banco Santander S.A. ADR Inc. (SAN) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today? - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

(PDF) A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens - researchgate.net

Jun 15, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

TJX Maintains Strong Dividend Program: Top Retail Chain Announces $0.425 Per Share Payout - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days - Akron Beacon Journal

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx announces presentation of results for DNA pol IIIC inhibitors - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Acurx (ACXP) Advances Antibiotic Candidate for C. difficile Treatment | ACXP Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Warner Bros. Discovery to split into two companies, dividing cable and streaming services - WFMZ.com

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough: New Antibiotic Class Shows Promise Against Drug-Resistant C. DifficilePhase 3 Ready - Stock Titan

Jun 09, 2025
pulisher
Jun 04, 2025

Clostridium Difficile Infections Pipeline 2025: MOA and ROA - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Popular Inc Delivers Double Income Stream: New Preferred Stock Dividend Plus Trust Securities Distribution - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Exclusive: Aptar Leadership Team Set for Strategic Updates at Major Investment Conferences - Stock Titan

Jun 02, 2025
pulisher
May 29, 2025

Medical Properties Trust Dividend Alert: $0.08 Per Share Payable July 17Key Dates Inside - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Exicure Faces Nasdaq Delisting Risk: 60 Days to Submit Compliance Plan for Late Q1 Filing - Stock Titan

May 28, 2025
pulisher
May 23, 2025

Ardent Health Partners Streamlines Brand Identity: What the New Corporate Name Means for Investors - Stock Titan

May 23, 2025
pulisher
May 22, 2025

Chikungunya wins boost Valneva; overall infectious disease stocks fall - BioWorld MedTech

May 22, 2025
pulisher
May 21, 2025

ACXP Stock: Selling Stockholder to Offload Shares with No Procee - GuruFocus

May 21, 2025

Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Acurx Pharmaceuticals Inc Stock (ACXP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Sailer Carl
Director
Jan 06 '25
Buy
1.01
24,631
25,000
137,183
LUCI DAVID P
President and CEO
Jan 06 '25
Buy
1.01
49,261
50,000
1,097,458
Donohue James J.
Director
Jan 06 '25
Buy
1.01
9,852
10,000
22,352
DELUCCIA ROBERT J
Director
Jan 06 '25
Buy
1.01
49,261
50,000
1,010,196
DEAN JACK H
Director
Jan 06 '25
Buy
1.01
9,852
10,000
21,776
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Cap:     |  Volume (24h):